Latest news
Loading news…
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
ReViral was acquired by Pfizer in 2022 for $525M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
13
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Stevenage, Herefordshire, United Kingdom
Key People at ReViral
Executive Chairman of the Board
Founder and Project Director
Founder and Chief Scientific Officer
13
professional contacts at ReViral
Contact execs at ReViral →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ReViral
Loading news…
FAQs about ReViral
People who checked this page also checked these
Browse the full Acquirezy directory.